
|Videos|November 9, 2021
Why future research must be conducted for prevention of LUTS and BPH
Author(s)Urology Times staff
“Currently, there is no role for statins in management of LUTS,” says Jordan J. Kramer, MD.
Advertisement
In this video, Jordan J. Kramer, MD, discusses why the findings of the REDUCE trial warrant further research into the prevention of LUTS and BPH. Kramer is a PGY4 urology resident at Cedars Sinai Medical Center, Los Angeles, California.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants 510(k) clearance to Break Wave lithotripsy device for kidney stones
2
Practical guide to female pelvic organ–sparing radical cystectomy
3
CaverSTIM device shows initial promise for post-prostatectomy erectile dysfunction
4
Targeting BCG resistance in high-risk NMIBC
5





